Newswise — The 8th Joint ACTRIMS-ECTRIMS meeting – the largest international conference focused on research in multiple sclerosis (MS), will be held in a virtual format from September 11-13, 2020, with a special encore session featuring Late-Breaking News and a COVID-19 Session on September 26. At this virtual conference – MSVirtual2020 – highly regarded scientists, neurologists, clinicians and researchers from around the world will be presenting the latest research, clinical trial outcomes and diagnostic advances in multiple sclerosis (MS). Registered reporters will have access to the full program and press events.
MSVirtual2020 will have a Newsroom that will house material that media can use such as bios of leaders and key speakers, MS infographics, MSVirtual2020 press releases, videos of ACTRIMS and ECTRIMS leaders, late breaker investigator summary videos (Available September 21 for media-only, under embargo), and other materials that may be of interest. This Newsroom can be found at: https://www.newswise.com/home/actrims.
Additionally, this Newsroom site will host three live press events for media-only. These events are designed to provide reporters with opportunities to hear from leaders and experts directly, ask them questions on the presentations being featured at the conference, hear clinical outcomes and breakthroughs (as well as some of the key advances being made in treatment, diagnostics and technologies as well as rehabilitation). There will also be a special press event focused on the late breakers and the Impact of COVID-19 on MS. The abstracts for this event will be available upon request to the press manager on September 21st. The sessions will have a live Q&A session where media will be able to ask questions directly to the late breaker investigators and the COVID-19 presenters.
Link to Press Events:
- The link will be: https://newswiselive.zoom.us/j/7459578068
PRESS EVENTS
Opening Press Conference with ACTRIMS and ECTRIMS Leaders with live Q&A (Media only)
- Date: Friday, September 11th @8:00 a.m. ET
- Focus: Key Highlights of Conference by ACTRIMS and ECTRIMS leaders
- Featured Speakers:
- Jeffrey Cohen, MD, President of ACTRIMS, Director of Mellen Center for Multiple Sclerosis Doctors, Cleveland Clinic
- Bernhard Hemmer, PhD, President of ECTRIMS and Director of the Neurology Clinic Technical University of Munich (TUM),
- Benjamin Segal, MD, Scientific Program Committee Co-Chair of MSVirtual2020 and chair of the Department of Neurology and Director of the Neurological Research Institute at The Ohio State University College of Medicine,
- Maria Pia Amato, MD, Scientific Program Committee Co-Chair of MSVirtual2020, and Associate Professor of Neurology and head of MS Unit at the Department of Neurology, University of Florence
- Link to Press Event: https://newswiselive.zoom.us/j/7459578068
- Virtual Coffee Break with ACTRIMS & ECTRIMS Presidents with an interactive Q&A (Media Only)
- Date: Sunday, September 13th @ 7:30 a.m. ET
- Focus: A Q&A session where media will have the opportunity to ask the Presidents questions regarding key conference presentations, clinical trial outcomes, advances in therapeutic research, technology and rehabilitation, and garner commentary from them.
- Featured Leaders:
- Jeffrey Cohen, MD, President of ACTRIMS, and Director of Mellen Center for Multiple Sclerosis Doctors, Cleveland Clinic
- Bernhard Hemmer, PhD, President of ECTRIMS and Director of the Neurology Clinic Technical University of Munich (TUM),
- Link to Press Event: https://newswiselive.zoom.us/j/7459578068
Upcoming as part of the MSVirtual2020 Encore session:
- Late-Breaker and COVID-19 Press Event – Live Q&A with Investigators (Media only)
- Date: Friday, September 25th @ 9:00 a.m.ET
- Focus: Live Q&A with Late Breaker and special COVID-19 Investigators
- Abstracts Available Under embargo as of September 21 upon request to press manager: [email protected]
- Featured Speakers: Late Breaker Investigators and COVID-19 Presenters
- Link to Press Event: https://newswiselive.zoom.us/j/7459578068
RSS